Your browser doesn't support javascript.
loading
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.
Nasioudis, Dimitrios; Wang, Xiaolei; Dhillon, Gurdial; Latif, Nawar; Ko, Emily M; Giuntoli, Robert L; Gershenson, David; Fader, Amanda; Carey, Mark; Simpkins, Fiona.
  • Nasioudis D; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA dimitrios.nasioudis@pennmedicine.upenn.edu.
  • Wang X; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Dhillon G; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Latif N; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Ko EM; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Giuntoli RL; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Gershenson D; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Fader A; The Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Carey M; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Simpkins F; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Int J Gynecol Cancer ; 33(12): 1906-1912, 2023 Dec 04.
Article en En | MEDLINE | ID: mdl-37879909

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article